QingSong Health Corporation (HKG:2661)
Hong Kong · Delayed Price · Currency is HKD 5.93
+0.15 (2.60%)
Jul 31, 2026, 4:08 PM HKT
QingSong Health Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 343.01 | 362.58 | 293.22 | 295.61 |
Short-Term Investments | 614.06 | - | 28.42 | - |
Cash & Short-Term Investments | 957.07 | 362.58 | 321.64 | 295.61 |
Cash Growth | 163.96% | 12.73% | 8.80% | - |
Accounts Receivable | 117 | 143.9 | 172.18 | 104.83 |
Other Receivables | 11.73 | 13.2 | 13.3 | 9.93 |
Receivables | 128.73 | 157.11 | 185.48 | 114.75 |
Other Current Assets | 74.78 | 62.04 | 93.91 | 175.21 |
Total Current Assets | 1,161 | 581.72 | 601.03 | 585.57 |
Property, Plant & Equipment | 5.67 | 1.88 | 5.86 | 9.07 |
Long-Term Investments | 5.91 | 84.41 | 81.89 | - |
Other Intangible Assets | 19.78 | 19.87 | 17.65 | 17.7 |
Long-Term Deferred Tax Assets | - | 1.35 | - | - |
Total Assets | 1,192 | 689.23 | 706.43 | 612.34 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 32.91 | 48.79 | 57.08 | 21.55 |
Accrued Expenses | 92.27 | 81.31 | 113.38 | 101.18 |
Short-Term Debt | - | 1,754 | 1,683 | 1,601 |
Current Portion of Leases | 3.38 | 0.04 | 4.41 | 4.03 |
Current Income Taxes Payable | 1.39 | 3.12 | 1.21 | 0.46 |
Current Unearned Revenue | 16.75 | 7.03 | 22.76 | 64.98 |
Other Current Liabilities | 35.81 | 4.77 | 11.13 | 51.48 |
Total Current Liabilities | 182.5 | 1,899 | 1,893 | 1,845 |
Long-Term Leases | - | 0.02 | 0.09 | 3.86 |
Long-Term Deferred Tax Liabilities | 7.23 | 9.12 | 10.83 | 4.47 |
Total Liabilities | 189.73 | 1,908 | 1,904 | 1,853 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0.14 | 0.05 | 0.05 | 0.05 |
Retained Earnings | -1,507 | -1,128 | -1,112 | -1,185 |
Comprehensive Income & Other | 2,509 | -91.09 | -86.28 | -55.48 |
Total Common Equity | 1,002 | -1,219 | -1,198 | -1,241 |
Minority Interest | - | - | 0.13 | 0.15 |
Shareholders' Equity | 1,002 | -1,219 | -1,198 | -1,241 |
Total Liabilities & Equity | 1,192 | 689.23 | 706.43 | 612.34 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 3.38 | 1,754 | 1,688 | 1,609 |
Net Cash (Debt) | 953.7 | -1,391 | -1,366 | -1,313 |
Net Cash Growth | - | - | - | - |
Net Cash Per Share | 11.51 | -13.78 | -6.75 | -16.40 |
Filing Date Shares Outstanding | 206.37 | 80.07 | 80.07 | 80.07 |
Total Common Shares Outstanding | 206.37 | 80.07 | 80.07 | 80.07 |
Working Capital | 978.09 | -1,317 | -1,292 | -1,259 |
Book Value Per Share | 4.86 | -15.22 | -14.96 | -15.50 |
Tangible Book Value | 982.45 | -1,238 | -1,216 | -1,259 |
Tangible Book Value Per Share | 4.76 | -15.47 | -15.18 | -15.72 |